Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
American Express
AXP
5
Charter Communications
CHTR
JP Stock MarketDetailed Quotes
4588 Oncolys BioPharma
- 559
- +2+0.36%
20min DelayNoon Break May 9 11:26 JST
13.95BMarket Cap-7.24P/E (Static)
565High557Low71.00KVolume557Open557Pre Close39.80MTurnover91852wk High0.32%Turnover Ratio24.96MShares42052wk Low-77.17EPS TTM12.50BFloat Cap4410Historical HighLossP/E (Static)22.36MShs Float401Historical Low-77.17EPS LYR1.44%Amplitude--Dividend TTM5.05P/B100Lot Size--Div YieldTTM
About Oncolys BioPharma Company
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Company Profile
Symbol4588
Company NameOncolys BioPharma
Founded2004-03-18
MarketTSE Growth
Fiscal Year Ends12-31
Address4-1-28 Toranomon Toranomon Towers Office
Zip Code105-0001
Phone03-5472-1578
Websitewww.oncolys.com
Company Executives
- Name
- Position
- Salary
- Yasuo Urata
- President and Chief Executive Officer, Research and Development and CMC
- --
- Yasunari Katagihara
- Director of Business Development and Risk Management
- --
- Yasushi Saitou
- Independent Director
- --
- Naoko Iino
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting